Get $80 off the Apple Watch SE for a limited time at Amazon

All products featured here are independently selected by our editors and writers. If you buy something through links on our site, Mashable may earn an affiliate commission.
SAVE $80: As of June 3, the Apple Watch SE (GPS, 40mm) is on sale for $169 at Amazon. This is 32% off its list price of $249.
Opens in a new window
Credit: Apple
Apple Watch SE (2nd Gen)
$169 at Amazon $249 Save $80
Get Deal
Some smartwatches come with very high price tags, but if you're looking for something that just covers the basics, there are quite a few budget-friendly options to look through. If you're an Apple user, the Apple Watch SE is a pick that's worth checking out. That's especially true now as it's currently discounted at Amazon.
The Apple Watch SE (2nd Gen, GPS, 40mm) has received a 32% discount at Amazon, dropping its price from $249 to $169. This discount applies to multiple color options as well, so you can choose between the starlight aluminum case with a lake green sport loop, the silver aluminum case with denim sport band, the silver aluminum case with blue cloud sport loop, the midnight aluminum case with midnight sport band, the midnight aluminum case with ink sport loop, and the starlight aluminum case with starlight sport band.
SEE ALSO: The 11-inch Apple iPad (A16 chip) is back to its best-ever price at Amazon
The Apple Watch SE has plenty of features to help you out throughout the day. This includes health tracking for heart rate and sleep, safety features like Fall Detection, Crash Detection, and Emergency SOS, and activity tracking to help with your fitness goals. It also fits in perfectly with an Apple ecosystem, allowing you to send texts or take calls from your wrist.
Don't miss out on 32% off the Apple Watch SE (2nd Gen, GPS, 40mm) at Amazon.
If you're hoping for a little bit more from your smartwatch, the Apple Watch Series 10 is also on sale at Amazon right now. It's currently back down to its lowest-ever price, so there's no better time than now to grab it.
Roku Ultra 4K Ultimate Streaming Player (2024 Release) — $79.99 (List Price $99.99)
Beats Pill Bluetooth Speaker — $99.95 (List Price $149.95)
Roborock Qrevo Master Robot Vacuum and Mop — $899.99 (List Price $1599.99)
Apple AirTag (4-Pack) — $74.99 (List Price $99.00)
DualSense Edge Wireless Controller — $169.00 (List Price $199.99)

Try Our AI Features

Explore what Daily8 AI can do for you:

Learn with AIFact CheckingText to SpeechAI Summary

Related Articles

Android Authority

19 minutes ago

• Android Authority

The Kiwi Ears Étude deliver tactile bass with vibration-powered IEM tech

Paul Jones / Android Authority TL;DR The Kiwi Ears Étude in-ear monitor (IEM) introduces Kiwi Vibration Transducer (KVT) tech for tactile low-end immersion. The IEMs combine 10mm beryllium-plated dynamic drivers with three balanced armatures. The Étude are on sale now for $119 at Amazon, Linsoul, and other retailers. Kiwi Ears recently unveiled the Étude, a pair of high-end in-ear monitors (IEMs) that the brand promises can deliver exceptional bass response via the brand's all-new Kiwi Vibration Transducer (KVT) technology. Unlike conventional bone conduction tech, KVT introduces a scaled-down tactile vibration system akin to what's found in Bluetooth vibration speakers, which Kiwi Ears promises will bring a physical edge to low-mid audio reproduction. The Étude are powered by 10mm beryllium-electroplated dynamic drivers, engineered to act like subwoofers. The driver aims to deliver crisp, fast kick drums and lush bass guitar tones. Paired with the KVT's vibration-enhanced plate system — driven by suspended N52 neodymium magnets — the result is what Kiwi Ears describes as a deep, rumbling low-end with 3D-like imaging. Paul Jones / Android Authority The Étude also house three custom-balanced armature drivers: a dedicated midrange driver tuned for vocal and instrumental clarity, and a dual ultra-high frequency tweeter to enhance microdetails and ambient textures. A flat midrange and carefully extended treble round out the tuning, with Kiwi Ears aiming for a lifelike, neutral profile. Kiwi also says the Étude are tuned with an 8dB sub-bass lift, grounded by a 250Hz crossover shelf to preserve vocal presence without adding coloration. It hopes this will bridge tactile impact with high-fidelity detail. Are the Kiwi Ears Étude worth it? Paul Jones / Android Authority I've been testing the Étude myself for the past week, and what has stuck with me most is how physical the bass felt compared to other IEMs that lack vibration drivers. Tracks with heavy low-end didn't just sound deep, they felt like they were pressing gently against my ear. Beyond the bass response, the tonal balance is also impressively refined. Vocals are clear, with a lifelike texture that sits well in the mix, and the upper registers stay smooth without veering into harsh territory. Instrument separation and soundstaging are also great across everything from driving metal to thumping cinematic scores. If you like genres that thrive on dynamics and layering, the Kiwi Ears Étude are definitely worth a look. Even with the unique drivers, these IEMs are tuned in a way that won't just satisfy bassheads, though some vocal tracks take on a slightly boxy or reverberant tone when the vibration tech really kicks in. Overall, if you like genres that thrive on dynamics and layering, the Étude are definitely worth a look. The Kiwi Ears Étude are on sale now on Amazon, priced at $119 MSRP, or can be bought from Linsoul, Kiwi Ears' parent brand. Kiwi Ears Étude Kiwi Ears Étude MSRP: $119.99 IEMs with innovative vibration tech. Experience deep, tactile bass with the Kiwi Ears Étude, featuring the innovative Kiwi Vibration Transducer (KVT) and a powerful 10mm Beryllium-plated dynamic driver. See price at Amazon Save $5.95

Yahoo

20 minutes ago

• Yahoo

Is This the Real Reason Apple Is So Far Behind Its Rivals on Artificial Intelligence?

Apple's valuation has nosedived this year as it has fallen behind its peers on next-gen technologies. The company's researchers aren't convinced that generative artificial intelligence can reason like humans. The business has struggled to generate much growth in recent quarters. 10 stocks we like better than Apple › Apple (NASDAQ: AAPL) has disappointed investors this year. It has delayed some artificial intelligence (AI) features for its iPhones until next year, and that has resulted in a lot of bearishness around the business as there are rival phones with advanced AI capabilities already available. Shares of Apple are down more than 21% thus far in 2025 (as of June 13), with its valuation dipping below the $3 trillion mark. AI is a hot topic these days, with consumers seeking the latest tech on their phones to help with many day-to-day tasks. However, Apple recently published a report about AI that could shed some light as to why it may not be leading the charge and investing as heavily in next-gen technologies as other tech companies. Researchers at Apple have been testing multiple AI reasoning models, and while they have seen that they can perform better than standard models, they fail as tasks become more complex. As a result, the researchers believe that there are limits to the reasoning that AI can achieve, and they don't appear to be as convinced of its abilities as the general public. They found that the models couldn't follow steps in complex tasks and appeared to rely heavily on the familiarity of data, as opposed to applying advanced reasoning skills. AI chatbots have become more sophisticated because they have been trained on existing data, but the ability for them to truly reason like humans is by no means a certainty. If Apple isn't convinced of the potential that AI possesses, that may be part of the reason it hasn't been investing as heavily in these types of technologies as its peers. Whether or not AI can reason like a human doesn't excuse the fact that Apple has fallen well behind other companies in terms of innovation. While Apple has made changes to the look and feel of its icons with its Liquid Glass design, the company's newest iPhones haven't given consumers a compelling reason to upgrade their devices. Apple's product sales over the six-month period ending March 29 have totaled $166.7 billion -- up just 2% from the same period last year. And iPhone revenue during that stretch was nearly unchanged. Lack of growth and innovation is a big problem for Apple these days. Regardless of whether it's completely sold on AI or not, the company needs to be doing more in advancing its phones so they don't fall behind the competition. Things like cross-app awareness, extracting information from photos to fill in forms, and integrating with third-party apps are some of the AI features that could be coming to iPhones next year. But whether that will be sufficient to keep up with rivals is questionable. While the company has built up a strong ecosystem of products and services, the danger is that customers may eventually see a reason to jump ship toward more innovative devices. Apple's stock has struggled this year, but it's still not a terribly cheap buy, trading at 31 times its trailing earnings. At that kind of multiple, investors might expect to see much more growth from the business. I believe that a discount is warranted for Apple stock, given the company's lack of innovation and growth. While the business is still robust and generating fantastic free cash flow and profits, its future growth is questionable, and that's a big reason investors are ditching Apple for other growth stocks instead. It can still make for a good long-term buy, but at an elevated valuation, I would look for other investments to buy. Before you buy stock in Apple, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Apple wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $658,297!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $883,386!* Now, it's worth noting Stock Advisor's total average return is 992% — a market-crushing outperformance compared to 172% for the S&P 500. Don't miss out on the latest top 10 list, available when you join . See the 10 stocks » *Stock Advisor returns as of June 9, 2025 David Jagielski has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Apple. The Motley Fool has a disclosure policy. Is This the Real Reason Apple Is So Far Behind Its Rivals on Artificial Intelligence? was originally published by The Motley Fool Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data

CNET

24 minutes ago

• CNET

This Kid's Cough Syrup Was Recalled. These Are the Foodborne Illness Symptoms It Can Cause

On Wednesday, the FDA reported that five lots of Little Remedies Honey Cough Syrup, a 100% natural children's cough medicine for ages 1 and up, were voluntarily recalled by Medtech Products. The kid's cough syrup was found to be contaminated by Bacillus cereus, a bacterium that can cause two types of foodborne illnesses. The five affected lots were distributed in the US both online and in retail stores from Dec. 14, 2022, to June 4, 2025. The lot numbers are 0039, 0545, 0640, 0450 and 1198, while the affected expiration dates extend to December 2026. The FDA reports that "no serious adverse events have been reported to date." This cough syrup contains three ingredients: honey, purified water and a natural preservative. Amazon What to do if you bought Little Remedies Honey Cough Syrup If you purchased a Little Remedies Honey Cough Syrup that has been recalled, stop using it immediately. If your child has experienced any issues that may be related to this product, contact their doctor. For reimbursement, you can email Medtech at medicalaffairs@ contact via its website at or by phone at (800) 754-8853, Monday through Friday from 8:30 a.m. to 5:30 p.m. Eastern time. Any reactions or quality issues can be reported to the FDA's MedWatch Adverse Event Reporting program. What foodborne illness symptoms can it cause? The FDA reports that Bacillus cereus or B. cereus is a bacterium that can cause two types of foodborne illnesses. The first type can start 1 to 6 hours after consumption of the contaminated food or drink. Symptoms include: stomach cramps, vomiting and nausea. The second type of foodborne illness caused by Bacillus cereus can occur 8 to 16 hours after consumption. Its symptoms are diarrhea and stomach cramps. "Although healthy individuals may suffer only short-term illness, exposure to high levels of foodborne B. cereus can cause death," the FDA said. If your child is demonstrating any of these symptoms related to the consumption of Little Remedies Honey Cough Syrup, contact their doctor immediately.